**Core tip:** Hwangryunhaedok-tang, a traditional herbal medicine, has been used to treat gastrointestinal diseases. Our data suggest that HHT can depolarize the pacemaker potentials of cultured interstitial cells of Cajal from mouse small intestine and may be a novel prokinetic agent.

INTRODUCTION
============

Herbal medicines are becoming increasingly popular in modern societies and substantial research has been conducted to establish their pharmacological properties according to scientific principles\[[@B1]\]. Since ancient times, people have used herbal medicines to treat and prevent disease. Due to their natural origins, herbal medicines have mild activities and few side effects; for this reason, many people are becoming increasingly interested in traditional herbal medicines\[[@B2]-[@B5]\].

Hwangryunhaedok-tang (HHT; Huang-Lian-Jie-Tang in Chinese or Oren-gedoku-to in Japanese) is a preparation that consists of Rhizoma Coptidis, Radix Scutellariae, Cortex Phellodendri and Fructus Gardenia\[[@B6]\]. HHT has been used to treat various symptoms, including inflammatory diseases\[[@B7],[@B8]\], cardiovascular diseases\[[@B9]\], diabetes mellitus\[[@B10]\], liver diseases\[[@B11],[@B12]\], brain injury\[[@B13],[@B14]\] and obesity\[[@B15]\]. HHT is also used to prevent or ameliorate gastrointestinal (GI) diseases\[[@B16]-[@B19]\]. HHT has been shown to have a preventive effect on the development of water immersion restraint (WIR) stress-induced acute gastric lesions in rats\[[@B16]\] and it suppresses the symptoms of inflammatory bowel disease by reducing levels of interleukin-8 (IL-8), leukotriene B4 (LTB4) and prostaglandin E2 (PGE2)\[[@B17]\]. In addition, HHT has been shown to prevent lethal indomethacin (IND)-induced enteropathy by decreasing adenosine deaminase (ADA) and, thus, increasing the adenosine levels in female BALB/c mice\[[@B18]\].

Interstitial cells of Cajal (ICCs) contribute to normal GI function, such as by generating electrical slow waves and mediating neuromuscular signaling\[[@B19]-[@B21]\]. Damage to ICCs or reductions in ICC numbers have been described in many GI motility disorders\[[@B22]-[@B24]\]; therefore, it is very important to understand the mechanisms of ICC pacemaker activity. However, no scientific evidence of a relationship between HHT and ICCs has been presented until now. In the present study, we investigated the effects of water extracts of HHT and its components on the pacemaker potentials of cultured ICCs from murine small intestine.

MATERIALS AND METHODS
=====================

Preparation of HHT extract
--------------------------

HHT was purchased from I-WORLD Pharmaceuticals (Incheon, South Korea). HHT (3.67 g) consists of Coptidis Rhizoma (0.67 g), Scutellariae Radix (1.00 g), Phellodendri Cortex (1.00 g) and Gardeniae Fructus (1.00 g). The materials were authenticated by Prof. Hyungwoo Kim (Division of Pharmacology, Pusan National University, School of Korean Medicine, Yangsan, Korea). HHT extract (HHTE) was prepared by boiling HHT in water for three hours. The standard adult dose of HHTE is 10-15 g (crude material) per day. More information about HHTE can be found at the I-WORLD Pharmaceuticals Homepage (<http://i-pharm.koreasme.com>). HHTE was dissolved in distilled water at a concentration of 0.5 g (crude drug)/mL and stored in a refrigerator until required.

Reagents
--------

Geniposide, berberine chloride, baicalin and wogonin were purchased from Wako (Japan). High-performance liquid chromatography (HPLC)-grade water and methanol were obtained from JT Baker Inc. (Phillipsburg, NJ, United States). Trifluoroacetic acid was purchased from Sigma-Aldrich (St. Louis, MO, United States).

Preparation of standard solutions
---------------------------------

Each standard compound (geniposide, berberine chloride, baicaline and wogonin) was accurately weighed and dissolved in methanol at a concentration of 1000 g/mL and the solution was 10-fold diluted before injection.

Chromatographic conditions
--------------------------

An Agilent 1200 (Agilent Technologies, Santa Clara, CA, United States) equipped with a quaternary pump, autosampler, column oven and diode-array detector was used. Acquired data were processed using Chemstation software (Ver. B. 03. 02). Chromatographic separation was performed on an XDB C~18~ column (4.6 mm × 150 mm, 5 μm; Agilent, United States) at 35 °C. The mobile phase consisted of water with 0.1% trifluoroacetic acid (A) and methanol (B). The following program was used: 30% (B) for 1 min, 30%-80% (B) over 1 min-13 min and 80% (B) for 1 min, which was followed by a re-equilibration to 30% (B). The flow rate was set at 0.8 mL/min and the injection volume was 10 μL. The detection wavelengths were 240 nm for geniposide, 260 nm for berberine chloride and 275 nm for baicalin and wogonin.

Identification of standard compounds in HHTE
--------------------------------------------

Standard compounds were detected in the chromatogram of HHTE at the following retention times: 5.2 min for geniposide, 9.1 min for berberine chloride, 10.1 min for baicalin and 14.7 min for wogonin (Figure [1](#F1){ref-type="fig"}).

![Effects of water extract of Hwangryunhaedok-tang on the pacemaker potentials of cultured interstitial cells of Cajal from murine small intestine. A-D: HHTE (0-50 mg/mL) induced pacemaker potential depolarizations and decreased amplitudes in a concentration-dependent manner. Responses to HHTE are summarized (E-G). Bars indicate the means ± SEMs. ^e^*P* \< 0.001: significantly different from the control. CTRL: Control; HHTE: Water extract of Hwangryunhaedok-tang.](WJG-23-5313-g001){#F1}

Ethics
------

We conducted the animal care and experiments in accordance with the guidelines issued by the Institutional Animal Care and Use Committee (IACUC) at Pusan National University (Busan, Republic of Korea; Approval no. PNU-2015-1036) and those issued by the National Institute of Health Guide for the Care and Use of Laboratory Animals.

Preparation of ICC and ICC clusters
-----------------------------------

ICR mice (Samtako Bio Korea Co., Ltd., Osan, South Korea; 3-7 day-old; weighing 1.9 g-2.2 g) of either sex were used and kept under controlled conditions (20 °C ± 3 °C, RH 49% ± 6% and light on 7 a.m.-7 p.m.). The small intestines were removed and opened; then, the luminal contents were cleaned using Krebs-Ringer bicarbonate solution and the obtained tissues were pinned to the bases of Sylgard dishes. Mucosae were removed and small tissue strips of intestine muscle were equilibrated for 25 min in Ca^2+^-free Hank's solution with the following solutions (in mmol/L): KCl 5.36, NaCl 125, NaOH 0.34, Na~2~HCO~3~ 0.44, glucose 10, sucrose 2.9 and HEPES 11 (pH 7.4). Cells were then dispersed in an enzyme solution \[1.3 mg/mL collagenase (Worthington Biochemical, Lakewood, NJ, United States), 2.1 mg/mL bovine serum albumin (Sigma-Aldrich, St. Louis, MO, United States), 2.6 mg/mL trypsin inhibitor (Sigma-Aldrich, St. Louis, MO, United States) and 0.50 mg/mL ATP (Sigma-Aldrich, St. Louis, MO, United States)\]. Cells were then cultured at 37 °C in a 95% O~2~-5% CO~2~ incubator in smooth muscle growth medium (SMGM) (Clonetics, San Diego, CA, United States) supplemented with 2% antibiotics/antimycotics (Gibco, Grand Island, NY, United States) and 5 ng/mL of murine stem cell factor (SCF) (Sigma-Aldrich, St. Louis, MO, United States). All experiments were performed on ICC cells that were cultured for \< 12 h. ICCs were identified immunologically using an anti-c-kit antibody (phycoerythrin (PE)-conjugated rat anti-mouse c-kit monoclonal antibody) (eBioscience, San Diego, CA, United States) at a dilution of 1:50 for 20 min\[[@B25]\]. Because ICCs differed morphologically from other cell types in culture, they were identified by phase contrast microscopy after incubation with anti c-kit antibody.

Patch-clamp experiments
-----------------------

The cells were transferred onto a solution chamber on the stage of an inverted microscope (IX70, Olympus, Japan). The whole-cell patch-clamp technique was used to record the membrane potentials (current clamp) of cultured ICCs as described previously\[[@B21],[@B22]\] and an Axopatch 200B amplifier (Axon Instruments, Foster City, CA, United States) was used to amplify membrane potentials. The bath solution \[Normal Tyrode (NT)\] contained 135 mmol/L NaCl, 5 mmol/L KCl, 2 mmol/L CaCl~2~, 1 mmol/L MgCl~2~, 10 mmol/L glucose and 10 mmol/L HEPES, with a pH adjusted to 7.4 using NaOH. The internal solution contained 145 mmol/L Cs-glutamate, 8 mmol/L NaCl, 10 mmol/L BAPTA and 10 mmol/L HEPES-CsOH, with a pH adjusted to 7.2 with CsOH. All experiments were performed at 30-32 °C.

Drugs
-----

Y25130, RS39604 and SB269970 were purchased from Tocris Bioscience (Bristol, United Kingdom) and all other drugs were obtained from Sigma-Aldrich (St. Louis, MO, United States). For stock solutions, all drugs were dissolved in distilled water or dimethylsulfoxide (DMSO) and stored at -20 °C. The final concentration of DMSO in the bath solution was always \< 0.1%. Furthermore, the addition of these chemicals did not alter the bath solution pH.

Statistical analysis
--------------------

The results are expressed as the means ± SEMs. N values refer to the numbers of cells used in the experiments. For multiple comparison analysis, we used one-way ANOVA with Bonferroni's *post hoc* comparison. For statistical analyses, we used Prism 6.0 (GraphPad Software Inc., La Jolla, CA, United States) and Origin version 8.0 (OriginLab Corporation, Northampton, MA, United States). *P* values \< 0.05 were considered statistically significant.

RESULTS
=======

Functional components of HHTE
-----------------------------

The presence of geniposide, berberine chloride, baicalin and wogonin in HHTE was established by HPLC and their levels were quantified using calibration curves obtained with purchased standards\[[@B26]\]. Validation of the method confirmed its reliability and stability. The contents of the four marker components of HHTE by HPLC were 2.684% ± 0.014% in geniposide, 0.993% ± 0.006% in berberine chloride, 5.081% ± 0.027% in baicalin and 0.040% ± 0.003% in wogonin.

Effects of HHTE on the pacemaker potentials of ICCs
---------------------------------------------------

Using the whole-cell patch clamp technique, we investigated the characteristics of cell clusters. Cell clusters formed network-like structures after culture for \< 12 h and were viable as demonstrated by the generation of spontaneous rhythmic contractions. ICCs were immunologically identified using an anti-c-kit antibody\[[@B25]\]. All experiments were performed at 30 °C-32 °C. Under the current clamp mode (*I* = 0), ICCs generated pacemaker potentials (Figure [1A](#F1){ref-type="fig"}) with a mean resting membrane potential of -58.3 ± 1.5 mV and a mean amplitude of 24.9 ± 1.1 mV. Initially, we examined the effects of HHTE on the pacemaker potentials of ICCs. HHTE (10-50 mg/mL) was found to depolarize pacemaker potentials and decrease their amplitudes in a concentration-dependent manner (Figure [1B](#F1){ref-type="fig"}-[D](#F1){ref-type="fig"}). In the presence of HHTE, the mean degrees of depolarization were 0.1 ± 0.1 mV at 10 mg/mL, 11.1 ± 0.9 mV at 20 mg/mL and 19.6 ± 1.1 mV at 30 mg/mL (Figure [1E](#F1){ref-type="fig"}, *n* = 17), the mean amplitudes were 24.8 ± 1.0 mV at 10 mg/mL, 12.1 ± 0.3 mV at 20 mg/mL and 1.7 ± 0.6 mV at 30 mg/mL (Figure [1F](#F1){ref-type="fig"}, *n* = 17) and the mean frequencies were 17.5 ± 1.0 cycles/min at 10 mg/mL, 4.5 ± 1.3 cycles/min at 20 mg/mL and 1.8 ± 0.9 cycles/min at 30 mg/mL (Figure [1G](#F1){ref-type="fig"}, *n* = 17). The summarized values showing the effects of HHTE on pacemaker potentials are provided in Figure [1E](#F1){ref-type="fig"}, 1F and 1G. These results show HHTE dose-dependently depolarizes the ICC pacemaker potentials.

HHTE mechanisms of action on ICCs
---------------------------------

To identify the connection between HHTE and its receptors in cultured ICCs, we studied the correlation of 5-HT receptors because these receptors are involved in GI tract motility, which is strongly associated with prokinetic activity\[[@B27]\]. In previous studies, 5-HT has been shown to interact with seven 5-HT receptor subtypes in the GI tract and only murine small intestine ICCs express three of these receptors (5-HT~3~, ~4~ and ~7~)\[[@B28],[@B29]\]. To confirm the 5-HT receptor subtypes involved in the effects of HHTE, we used the various 5-HT receptor antagonists and then treated samples with HHTE. A 5-HT~3~ receptor antagonist (Y25130), a 5-HT~4~ receptor antagonist (RS39604), or a 5-HT~7~ receptor antagonist (SB269970) was used to pretreat the samples at 10 μmol/L for 5 min; then, HHTE was added. In the case of pretreatment with Y25130, HHTE-induced pacemaker potential depolarization was blocked (Figure [2A](#F2){ref-type="fig"}) and HHTE-induced pacemaker potential depolarization in the presence of Y25130 was 0.8 ± 0.5 mV (*n* = 5; Figure [2D](#F2){ref-type="fig"} and E). RS39604 also blocked HHTE-induced pacemaker potential depolarization. HHTE-induced pacemaker potential depolarization in the presence of RS39604 was 0.5 ± 0.6 mV (*n* = 5; Figure [2B](#F2){ref-type="fig"}, D and E). However, pretreatment with SB269970 did not block the HHTE-induced pacemaker potential depolarization. HHTE-induced pacemaker potential depolarization in the presence of SB269970 was 19.4 ± 1.8 mV (n = 5; Figure [2C](#F2){ref-type="fig"}-E). These results indicate that HHTE affects ICCs in the murine small intestine through the 5-HT~3~ and 5-HT~4~ receptors.

![Effects of 5-HT receptor antagonists on water extract of Hwangryunhaedok-tang-induced pacemaker potential depolarizations in the cultured interstitial cells of Cajal of murine small intestine. A: Y25130 (a 5-HT3 receptor antagonist) inhibited HHTE-induced responses. B: A 5-HT4 receptor antagonist, RS39604, blocked HHTE-induced responses. C: A 5-HT7 receptor antagonist, SB269970, did not block HHTE-induced responses. D and E responses to 5-HT receptor antagonists are summarized. Bars indicate the means ± SEMs. ^a^*P* \< 0.05 and ^e^*P* \< 0.001: Significantly different from nontreated controls. CTRL: Control; HHTE: Water extract of Hwangryunhaedok-tang.](WJG-23-5313-g002){#F2}

Connection of G protein in HHTE-induced pacemaker potential depolarization in ICCs
----------------------------------------------------------------------------------

To determine whether G proteins are involved in HHTE-induced pacemaker potential depolarization, we used GDP-β-S (a non-hydrolysable guanosine 5' diphosphate analogue), which inhibits G-protein activation\[[@B30],[@B31]\]. HHTE (50 mg/mL) induced pacemaker potential depolarization in ICCs (Figure [1D](#F1){ref-type="fig"}); however, when GDP-β-S (1 mmol/L) was applied in the pipette solution, HHTE (50 mg/mL) only caused slight pacemaker potential depolarization (5.2 ± 0.3 mV, *n* = 5; Figure [3A](#F3){ref-type="fig"} and B). These results indicate that G protein is involved in HHTE-induced ICC pacemaker potential depolarization.

![Effects of GDP-β-S on water extract of Hwangryunhaedok-tang-induced pacemaker potential depolarizations in cultured interstitial cells of Cajal. A: When GDP-β-S (1 mmol/L) was applied in the pipette, HHTE did not depolarize the pacemaker potential. B and C: HHTE-induced responses are summarized. Bars indicate the means ± SEMs. ^e^*P* \< 0.001: Significantly different from nontreated controls. CTRL: Control; HHTE: Water extract of Hwangryunhaedok-tang.](WJG-23-5313-g003){#F3}

Effects of external and internal Ca^2+^ on HHTE-induced pacemaker potential depolarization in ICCs
--------------------------------------------------------------------------------------------------

Regulation of external and internal Ca^2+^ has an important role in mediating GI smooth muscle contraction and the generation of pacemaker potentials in ICCs\[[@B32]\]. To identify the roles of Ca^2+^, HHTE was applied in external Ca^2+^-free conditions or in the presence of an inhibitor of Ca^2+^-ATPase in the endoplasmic reticulum (thapsigargin). In the external Ca^2+^-free conditions, pacemaker potentials were abolished; under this condition, HHTE did not induce pacemaker potential depolarization (*n* = 6; Figure [4A](#F4){ref-type="fig"} and C). In addition, pretreatment with thapsigargin abolished pacemaker potentials and under this condition, HHTE also did not induce pacemaker potential depolarization (*n* = 5; Figure [4B](#F4){ref-type="fig"} and D). These results show that HHTE-induced pacemaker potential depolarization depends on internal and external Ca^2+^.

![Effects of external and internal Ca^2+^ on water extract of Hwangryunhaedok-tang-induced pacemaker potential depolarization in cultured interstitial cells of Cajal from murine small intestine. A: In external Ca2^+^-free conditions, the pacemaker potentials were abolished and HHTE had no effect. B: Thapsigargin abolished the pacemaker potentials and HHTE had no effects; C-E: HHTE-induced pacemaker potential depolarizations are summarized. Bars represent the means ± SEMs. ^e^*P* \< 0.001: Significantly different from untreated controls. CTRL: Control; HHTE: Water extract of Hwangryunhaedok-tang.](WJG-23-5313-g004){#F4}

Pathways mediating HHTE-induced pacemaker potential depolarization in ICCs
--------------------------------------------------------------------------

To determine whether HHTE-induced pacemaker potential depolarization is associated with protein kinase C (PKC) or Rho kinase, we pretreated ICCs with a PKC inhibitor (calphostin C, 10 μmol/L, Figure [5A](#F5){ref-type="fig"}) or a Rho kinase inhibitor (Y27631, 1 μmol/L, Figure [5B](#F5){ref-type="fig"}) for 5 min. HHTE-induced pacemaker potential depolarizations were not inhibited by calphostin C or Y27632 (Figure [5C](#F5){ref-type="fig"}). We confirmed that treatment with these inhibitors alone did not affect pacemaker potential depolarization. These results suggest that HHTE-induced pacemaker potential depolarization is not mediated by PKC or Rho kinase in the cultured ICCs of murine small intestine.

![Effects of protein kinase C inhibitor and Rho kinase inhibitor on water extract of Hwangryunhaedok-tang-induced pacemaker potential depolarizations in cultured interstitial cells of Cajal from murine small intestine. Both (A) calphostin C (a PKC inhibitor) and (B) Y27631 (a Rho kinase inhibitor) had no effects on the pacemaker potentials; under these conditions, HHTE induced pacemaker potential depolarizations. C and D responses to HHTE in the presence of calphostin C or Y27631 are summarized. Bars represent the means ± SEMs. ^e^*P* \< 0.001: significantly different from the nontreated control. CTRL: Control; HHTE: Water extract of Hwangryunhaedok-tang; PKC: Protein kinase C.](WJG-23-5313-g005){#F5}

Effects of Coptidis Rhizoma, Scutellariae Radix, Phellodendri Cortex and Gardeniae Fructus extracts in ICCs
-----------------------------------------------------------------------------------------------------------

We investigated the effects of the four components of HHT, Coptidis Rhizoma, Scutellariae Radix, Phellodendri Cortex and Gardeniae Fructus\[[@B6]\], in cultured ICCs from murine small intestine. All four components depolarized the pacemaker potentials and decreased the amplitudes of the pacemaker potentials (Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}) in a concentration-dependent manner. At a concentration of 30 μg/mL, Coptidis Rhizoma had a mean degree of depolarization of 13.1 ± 2.2 mV (Figure [6A](#F6){ref-type="fig"}, *n* = 7), Scutellariae Radix had a mean degree of depolarization of 0.6 ± 0.4 mV (Figure [6C](#F6){ref-type="fig"}, *n* = 7), Phellodendri Cortex had a mean degree of depolarization of 0.7 ± 0.6 mV (Figure [7A](#F7){ref-type="fig"}, *n* = 6) and Gardeniae Fructus had a mean degree of depolarization of 9.7 ± 1.5 mV (Figure [7C](#F7){ref-type="fig"}, *n* = 7). The summarized values and bar graph showing the effects of these components on pacemaker potentials are provided in Figures [6B](#F6){ref-type="fig"}, 6D, 6E, 7B, 7D and 7E. These results suggest that Coptidis Rhizoma and Gardeniae Fructus are the main components responsible for HHTE-induced pacemaker potential depolarizations in the cultured ICCs of murine small intestine.

![Effects of Coptidis Rhizoma and Scutellariae Radix on pacemaker potentials in cultured interstitial cells of Cajal from murine small intestine. A: Pacemaking activities of ICCs exposed to Coptidis Rhizoma (30 μg/mL) in current-clamp mode (*I* = 0); B: Coptidis Rhizoma (10-50 μg/mL) concentration-dependently induced pacemaker potential depolarization. Responses to Coptidis Rhizoma are summarized; C: Pacemaking activities of ICCs exposed to Scutellariae Radix (30 μg/mL) in the current-clamp mode (*I* = 0); D: Scutellariae Radix (10-100 μg/mL) concentration-dependently induced pacemaker potential depolarization. Responses to Scutellariae Radix are summarized; E: Frequency changes to Coptidis Rhizoma and Scutellariae Radix are summarized. Bars represent the means ± SEMs. ^b^*P* \< 0.01 and ^e^*P* \< 0.001: Significantly different from the control. CTRL: Control; CR: Coptidis Rhizoma; SR: Scutellariae Radix; ICCs: Interstitial cells of Cajal.](WJG-23-5313-g006){#F6}

![Effects of Phellodendri Cortex and Gardeniae Fructus on pacemaker potentials in cultured interstitial cells of Cajal from murine small intestine. A: Pacemaking activities of ICCs exposed to Phellodendri Cortex (30 μg/mL) in the current-clamp mode (*I* = 0); B: Phellodendri Cortex (10-100 μg/mL) concentration-dependently induced pacemaker potential depolarization. Responses to Phellodendri Cortex are summarized; C: Pacemaking activities of ICCs exposed to Gardeniae Fructus (30 μg/mL) in the current-clamp mode (*I* = 0); D: Gardeniae Fructus (10-100 μg/mL) concentration-dependently induced pacemaker potential depolarizations. Responses to Gardeniae Fructus are summarized; E: Frequency changes to Phellodendri Cortex and Gardeniae Fructus are summarized. Bars represent the means ± SEMs. ^a^*P* \< 0.05 and ^e^*P* \< 0.001: Significantly different from the control. CTRL: Control; PC: Phellodendri Cortex. GF: Gardeniae Fructus.](WJG-23-5313-g007){#F7}

DISCUSSION
==========

ICCs are located within and around smooth muscle layers of the GI tract and they control GI motility by acting as pacemaker cells\[[@B20]-[@B22],[@B33],[@B34]\]. The pacemaker functions of these cells result from the electrical slow waves generated and propagated in smooth muscles\[[@B20],[@B35]\]. Additionally, ICCs are connected to both nerve and smooth muscle cells and they are involved in mechanosensation and neurotransmission\[[@B32],[@B34],[@B36]\]. Many GI motility disorders, such as achalasia and inflammatory bowel disease, have been associated with ICC dysfunctions\[[@B37]\]. Therefore, understanding the mechanisms of ICC and pacemaker activity is very important. In the present study, we show that HHTE depolarized ICC pacemaker potentials through 5-HT~3~ and 5-HT~4~ receptors *via* external and internal Ca^2+^ regulation and *via* G protein-, PKC- and Rho kinase- independent pathways. Additionally, we tested the effects of HHTE on GI motility in mice *in vivo* and found that HHTE increased the GI motility in mice\[[@B26]\].

HHT has long been used as an herbal medicine to treat GI disorders in Asia\[[@B16]-[@B18]\]. Ohta et al\[[@B16]\] suggested that oral HHT prevents stress-induced acute gastric lesions in rats. Additionally, Zhou and Mineshita\[[@B17]\] reported that HHT showed anti-inflammatory and anti-ulcerative effects on trinitrobenzene-sulfonic acid (TNB)-induced colitis in rats. In that study, HHT was found to inhibit myeloperoxidase activity and to significantly decrease the IL-8, PGE2 and LTB4 levels. Therefore, the authors suggested that HHT may be useful for treating inflammatory bowel disease. In addition, Watanabe-Fukuda et al\[[@B18]\] observed that HHT prevented lethal indomethacin (IND)-induced enteropathy by downregulating adenosine deaminase (ADA) and thus upregulating adenosine (an anti-inflammatory nucleoside) levels. Furthermore, these authors reported that berberine, which is a major ingredient of HHT, suppressed ADA expression and reduced the incidence of lethality.

In the present study, we found that 5-HT~3~ or 5-HT~4~ receptors, *via* external and internal Ca^2+^ regulation and *via* G protein, were involved in HHTE-induced responses in ICCs. Of the seven 5-HT receptor subtypes, the 5-HT~3~ and 5-HT~4~ receptors are the most highly expressed and best understood 5-HT receptor subtypes in the GI tract\[[@B38],[@B39]\]. 5-HT~3~ receptors are ligand-gated cation channels that can initiate peristalsis and secretion in the GI tract\[[@B38]\]. Additionally, 5-HT~4~ receptors are G-protein-coupled metabotropic receptors and their activation regulates GI motility\[[@B39]\]. Furthermore, these receptors are coupled to G proteins, which have Ca^2+^/calmodulin-dependent activation\[[@B40],[@B41]\]. Additionally, in the present study, HHT-induced pacemaker potential depolarizations *via* 5-HT~3~ and 5-HT~4~ receptors were not inhibited by the Rho kinase inhibitor, Y27632, or the PKC inhibitor, calphostin (Figure [5](#F5){ref-type="fig"}). These results suggest that HHT-induced pacemaker potential depolarizations are independent of PKC and Rho kinase activation.

5-HT has played a major role in gut function regulation\[[@B42]\]. Among 5-HT receptors, 5-HT~3~ and 5-HT~4~ receptors have been the most widely investigated for gut motility\[[@B27]\]. 5-HT~3~ receptors are mainly targeted to treat diarrhea and abdominal pain\[[@B27],[@B43],[@B44]\] and 5-HT~4~ receptors are targeted to treat constipation\[[@B44],[@B45]\]. Although each agonist and antagonist has been used effectively, pharmacological agents of 5-HT receptors have problems in their clinical use because of deleterious side effects. In the present study, HHTE affects ICC pacemaker potentials through 5-HT~3~ and 5-HT~4~ receptors; therefore, HHTE may be used to treat diarrhea, abdominal pain and constipation, among other symptoms. Of note, future studies will have to be designed to determine the side effects of HHT.

The 5-HT~3~ receptor channels are the only ionotropic receptors within the 5-HT receptor family\[[@B46]-[@B48]\]. 5-HT~3~ receptors are involved in many pathophysiological processes, such as GI motility disorders and the development of nausea and vomiting\[[@B48]-[@B50]\]. Therefore, 5-HT~3~ receptors play an important role in GI motility functions. In this paper, we found that HHTE may activate 5-HT~3~ and 5-HT~4~ receptors; among them, 5-HT~4~ receptors may have the main role in regulating the ICC, whereas 5-HT~3~ receptors may have a supportive role. Additionally, when GDP-β-S (1 mmol/L) was applied in the pipette solution, we found that HHTE caused slight pacemaker potential depolarization (Figure [3](#F3){ref-type="fig"}), which might be due to the 5-HT~3~ receptor signaling pathway.

GI disorders are observed in Western and Eastern countries\[[@B51]\]. Because GI disorders are not lethal, the medications used to treat these disorders have a higher safety threshold than those for medications used to treat non-GI diseases. However, recent studies have highlighted the substantial health impacts of GI disorders\[[@B52]\]. Furthermore, several GI treatments have significant adverse effects, which has led to the withdrawal of cisapride and tegaserod from the market\[[@B53],[@B54]\]. Of note, herbal products are often used to treat GI disorders like irritable bowel syndrome\[[@B55],[@B56]\] and herbal medications have a desirable role in the treatment of GI disorders.

HHT consists of Coptidis Rhizoma, Scutellariae Radix, Phellodendri Cortex and Gardeniae Fructus\[[@B6]\]. We investigated the effects of these four constituents on the pacemaker potentials of ICCs to identify the components that are primarily responsible for the effect of HHT on ICC pacemaker potentials. All four components depolarized pacemaker potentials and decreased the amplitudes of pacemaker potentials in a concentration-dependent manner (Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}). However, Coptidis Rhizoma and Gardeniae Fructus were observed to have greater depolarizing effects. We will perform future experiments to determine the detailed effects of the HHT active elements (Coptidis Rhizoma and Gardeniae Fructus) and identified compounds (geniposide, berberine chloride, baicalin and wogonin) on ICC pacemaking potential.

ICCs are pacemaker cells that appear to play important roles in the determination and regulation of GI motility\[[@B19],[@B20]\]. HHTE depolarized the pacemaker potentials of ICCs in a G protein- and Ca^2+^-dependent manner. Based on the findings described in this study, we propose the following model of the effects of HHTE in ICCs. HHTE binds 5-HT~3~ and 5-HT~4~ receptors and HHTE-induced pacemaker potential depolarizations are G protein- and Ca^2+^-dependent in ICCs. An increase in intracellular Ca^2+^ induces membrane depolarizations on ICCs\[[@B57],[@B58]\]. In addition, these pacemaker potential depolarizations might be regulated by transient receptor potential melastatin 7 (TRPM7) and Ca^2+^-activated Cl^-^ (ANO1) channels\[[@B20],[@B59]\].

In the present study, HHTE was found to regulate ICC pacemaker potential depolarization in a G protein- and Ca^2+^-dependent manner. Accordingly, HHT may play an excitatory role in GI motility regulation. Additionally, because GI motility regulations are highly integrated behaviors between smooth muscle cells, ICCs and enteric nervous systems, further studies are needed to investigate the effects of HHT on other cells *in vitro* and *in vivo*.

In summary, our findings suggest that HHT can depolarize the pacemaker potentials of cultured ICCs from mouse small intestine. Future research should attempt to identify the components responsible for the effects of HHT and to determine their mechanisms of action *in vitro* and *in vivo*.

COMMENTS
========

Background
----------

Interstitial cells of Cajal (ICCs) are the pacemaker cells that generate slow waves in the gastrointestinal (GI) tract. Hwangryunhaedok-tang (HHT) (consisting of Coptidis Rhizoma, Scutellariae Radix, Phellodendri Cortex and Gardeniae Fructus) is a traditional herbal medicine used to treat GI disorders. However, despite the considerable use of HHT in traditional herbal medicine to treat GI dysfunction, little is known of the effects of a water extract of HHT (HHTE) on the pacemaker potentials of mouse small intestinal ICCs.

Research frontiers
------------------

The prokinetic effects of HHTE are mediated by the induction of pacemaker potentials in ICCs.

Innovations and breakthroughs
-----------------------------

HHTE dose-dependently depolarizes ICC pacemaker potentials through the 5-HT~3~ and 5-HT~4~ receptors *via* external and internal Ca^2+^ regulation as well as *via* G protein-, PKC- and Rho kinase-independent pathways.

Applications
------------

HHT may be a new target for pharmacological treatment of GI motility disorders.

Peer-review
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The authors investigated the effects of HHT (a traditional herbal medicine) on the pacemaker potentials of mouse ICCs, the results of study suggest that HHT dose-dependently depolarizes ICC pacemaker potentials through 5-HT~3~ and 5-HT~4~ receptors *via* external and internal Ca^2+^ regulation and *via* G protein- and MLCK-dependent pathways. These data are somewhat interesting.
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